CMV immune evasion and manipulation of the immune system with aging.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsJackson, Sarah E
van Baarle, Debbie
van den Berg, Sara P H
Benedict, Chris A
Hill, Ann B
Wills, Mark R
MetadataShow full item record
TitleCMV immune evasion and manipulation of the immune system with aging.
Published inGeroscience 2017, 39(3):273-91
PubliekssamenvattingHuman cytomegalovirus (HCMV) encodes numerous proteins and microRNAs that function to evade the immune response and allow the virus to replicate and disseminate in the face of a competent innate and acquired immune system. The establishment of a latent infection by CMV, which if completely quiescent at the level of viral gene expression would represent an ultimate in immune evasion strategies, is not sufficient for lifelong persistence and dissemination of the virus. CMV needs to reactivate and replicate in a lytic cycle of infection in order to disseminate further, which occurs in the face of a fully primed secondary immune response. Without reactivation, latency itself would be redundant for the virus. It is also becoming clear that latency is not a totally quiescent state, but is characterized by limited viral gene expression. Therefore, the virus also needs immune evasion strategies during latency. An effective immune response to CMV is required or viral replication will cause morbidity and ultimately mortality in the host. There is clearly a complex balance between virus immune evasion and host immune recognition over a lifetime. This poses the important question of whether long-term evasion or manipulation of the immune response driven by CMV is detrimental to health. In this meeting report, three groups used the murine model of CMV (MCMV) to examine if the contribution of the virus to immune senescence is set by the (i) initial viral inoculum, (ii) inflation of T cell responses, (iii) or the balance between functionally distinct effector CD4+ T cells. The work of other groups studying the CMV response in humans is discussed. Their work asks whether the ability to make immune responses to new antigens is compromised by (i) age and HCMV carriage, (ii) long-term exposure to HCMV giving rise to an overall immunosuppressive environment and increased levels of latent virus, or (iii) adapted virus mutants (used as potential vaccines) that have the capacity to elicit conventional and unconventional T cell responses.
- Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
- Authors: Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D
- Issue date: 2014 Aug
- Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence.
- Authors: Nikolich-Žugich J, van Lier RAW
- Issue date: 2017 Jun
- Diverse immune evasion strategies by human cytomegalovirus.
- Authors: Noriega V, Redmann V, Gardner T, Tortorella D
- Issue date: 2012 Dec
- Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.
- Authors: Gardner TJ, Tortorella D
- Issue date: 2016 Sep
- In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
- Authors: Lemmermann NA, Böhm V, Holtappels R, Reddehase MJ
- Issue date: 2011 May